Home
RMD
RMD News

Latest ResMed Inc. (RMD) News on May 16, 2025

Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025

GlobeNewswire

20 hours ago

Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025

Patient Monitoring Stocks Q1 Teardown: ResMed (NYSE:RMD) Vs The Rest

StockStory

a day ago

Patient Monitoring Stocks Q1 Teardown: ResMed (NYSE:RMD) Vs The Rest

Argus Research

2 days ago

RMD: Rating increased to a BUY

Argus Research

9 days ago

RMD: Raising target price to $254.00

3 Profitable Stocks to Consider Right Now

StockStory

10 days ago

3 Profitable Stocks to Consider Right Now

Is It Smart To Buy ResMed Inc. (NYSE:RMD) Before It Goes Ex-Dividend?

Simply Wall St.

13 days ago

Is It Smart To Buy ResMed Inc. (NYSE:RMD) Before It Goes Ex-Dividend?

This ResMed Insider Reduced Their Stake By 72%

Simply Wall St.

14 days ago

This ResMed Insider Reduced Their Stake By 72%

Resmed acquires independent diagnostic testing facility VirtuOx

Medical Device Network

14 days ago

Resmed acquires independent diagnostic testing facility VirtuOx

Intuitive wins new FDA nod for single port robot; Resmed buys diagnostic facility

MedTech Dive

14 days ago

Intuitive wins new FDA nod for single port robot; Resmed buys diagnostic facility

MT Newswires

15 days ago

ResMed Buys VirtuOx for Undisclosed sum

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

Zacks

15 days ago

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

Resmed Acquires VirtuOx

GlobeNewswire

15 days ago

Resmed Acquires VirtuOx

Resmed Inc (RMD): Jim Cramer Says “Remarkable Stock” — Did GLP-1 Drugs Just Hand It a Lifeline?

Insider Monkey

16 days ago

Resmed Inc (RMD): Jim Cramer Says “Remarkable Stock” — Did GLP-1 Drugs Just Hand It a Lifeline?

iRhythm Earnings: What To Look For From IRTC

StockStory

16 days ago

iRhythm Earnings: What To Look For From IRTC

RMD Q1 Earnings Call: Margin Expansion and Demand Generation Initiatives Define Quarter

StockStory

19 days ago

RMD Q1 Earnings Call: Margin Expansion and Demand Generation Initiatives Define Quarter

MMSI Stock Declines Despite Q1 Earnings Beating Estimates, Margins Up

Zacks

21 days ago

MMSI Stock Declines Despite Q1 Earnings Beating Estimates, Margins Up

ResMed (RMD) is a Top-Ranked Momentum Stock: Should You Buy?

Zacks

21 days ago

ResMed (RMD) is a Top-Ranked Momentum Stock: Should You Buy?

ResMed (NYSE:RMD) Reports Strong Q3 Earnings Growth and Declares US$0.53 Dividend

Simply Wall St.

22 days ago

ResMed (NYSE:RMD) Reports Strong Q3 Earnings Growth and Declares US$0.53 Dividend

MT Newswires

22 days ago

KeyBanc Adjusts Price Target on ResMed to $274 From $269, Maintains Overweight Rating

MT Newswires

22 days ago

Jefferies Adjusts Price Target on ResMed to $245 From $270, Maintains Hold Rating

MT Newswires

22 days ago

Piper Sandler Adjusts Price Target on ResMed to $248 From $260, Maintains Neutral Rating

MT Newswires

22 days ago

Morgan Stanley Adjusts Price Target on ResMed to $286 From $280, Maintains Overweight Rating

MT Newswires

22 days ago

JPMorgan Adjusts Price Target on ResMed to $290 From $286, Maintains Overweight Rating

MT Newswires

22 days ago

Mizuho Adjusts Price Target on ResMed to $250 From $265, Maintains Outperform Rating

MT Newswires

22 days ago

Wolfe Research Adjusts Price Target on ResMed to $200 From $195, Maintains Underperform Rating

Thomson Reuters StreetEvents

22 days ago

Q3 2025 Resmed Inc Earnings Call

Morningstar Research

22 days ago

Analyst Report: ResMed Inc.

MT Newswires

22 days ago

RBC Raises Price Target on ResMed to $255 From $247, Keeps Sector Perform Rating

ResMed Q3 Earnings and Revenues Beat, Stock Up in After-Market

Zacks

22 days ago

ResMed Q3 Earnings and Revenues Beat, Stock Up in After-Market

ResMed Inc (RMD) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

GuruFocus.com

22 days ago

ResMed Inc (RMD) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

Here's What Key Metrics Tell Us About ResMed (RMD) Q3 Earnings

Zacks

22 days ago

Here's What Key Metrics Tell Us About ResMed (RMD) Q3 Earnings

ResMed (RMD) Q3 Earnings and Revenues Surpass Estimates

Zacks

22 days ago

ResMed (RMD) Q3 Earnings and Revenues Surpass Estimates

ResMed’s (NYSE:RMD) Q1 Earnings Results: Revenue In Line With Expectations

StockStory

23 days ago

ResMed’s (NYSE:RMD) Q1 Earnings Results: Revenue In Line With Expectations

Earnings To Watch: ResMed (RMD) Reports Q1 Results Tomorrow

StockStory

24 days ago

Earnings To Watch: ResMed (RMD) Reports Q1 Results Tomorrow

Resmed Names Salli Schwartz as Chief Investor Relations Officer

GlobeNewswire

24 days ago

Resmed Names Salli Schwartz as Chief Investor Relations Officer

Earnings Preview: InMode (INMD) Q1 Earnings Expected to Decline

Zacks

25 days ago

Earnings Preview: InMode (INMD) Q1 Earnings Expected to Decline

MT Newswires

25 days ago

KeyBanc Adjusts ResMed Price Target to $269 From $280, Maintains Overweight Rating

What Analyst Projections for Key Metrics Reveal About ResMed (RMD) Q3 Earnings

Zacks

a month ago

What Analyst Projections for Key Metrics Reveal About ResMed (RMD) Q3 Earnings

ResMed (RMD) Reports Next Week: Wall Street Expects Earnings Growth

Zacks

a month ago

ResMed (RMD) Reports Next Week: Wall Street Expects Earnings Growth

MT Newswires

a month ago

Mizuho Securities Adjusts ResMed Price Target to $265 From $280, Maintains Outperform Rating

Argus Research

a month ago

RMD: Rating decreased to a HOLD

Here's Why ResMed (RMD) is a Strong Growth Stock

Zacks

a month ago

Here's Why ResMed (RMD) is a Strong Growth Stock

MT Newswires

a month ago

Baird Cuts Price Target on ResMed to $252 From $286, Maintains Outperform Rating

MT Newswires

a month ago

ResMed's Fiscal Q3 Likely to Meet Consensus Estimates; Faces Supply Chain Risks, UBS Says

Morningstar Research

a month ago

Analyst Report: ResMed Inc.

Argus Research

a month ago

RMD: Lowering target price to $241.00

Strength Seen in ResMed (RMD): Can Its 3.8% Jump Turn into More Strength?

Zacks

a month ago

Strength Seen in ResMed (RMD): Can Its 3.8% Jump Turn into More Strength?

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

StockStory

a month ago

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

ResMed (NYSE:RMD) Launches NightOwl Device to Simplify Home Sleep Apnea Testing Across US

Simply Wall St.

a month ago

ResMed (NYSE:RMD) Launches NightOwl Device to Simplify Home Sleep Apnea Testing Across US

ResMed Inc. (RMD): A Bull Case Theory

Insider Monkey

a month ago

ResMed Inc. (RMD): A Bull Case Theory

Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl™, Now Available Across the US

GlobeNewswire

a month ago

Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl™, Now Available Across the US

Resmed Inc. (RMD): Jim Cramer Says He Likes This Sleep Apnea Treatment Stock

Insider Monkey

a month ago

Resmed Inc. (RMD): Jim Cramer Says He Likes This Sleep Apnea Treatment Stock

Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025

GlobeNewswire

a month ago

Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025

Argus Research

a month ago

RMD: Rating increased to a BUY

Morgan Stanley Sees Near-Term Rally Ahead — Here Are 2 Stocks to Bet on It

TipRanks

2 months ago

Morgan Stanley Sees Near-Term Rally Ahead — Here Are 2 Stocks to Bet on It

Jim Cramer On ResMed Inc. (RMD) – “I’m With Mick! ResMed’s Doing Quite Well”

Insider Monkey

2 months ago

Jim Cramer On ResMed Inc. (RMD) – “I’m With Mick! ResMed’s Doing Quite Well”

Argus Research

2 months ago

RMD: Raising target price to $232.00

ResMed initiated with an Overweight at Morgan Stanley

TipRanks

2 months ago

ResMed initiated with an Overweight at Morgan Stanley

New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer

GlobeNewswire

2 months ago

New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer

New Product Launches Benefit GMED Stock Amid Macro Issues

Zacks

2 months ago

New Product Launches Benefit GMED Stock Amid Macro Issues

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

Zacks

2 months ago

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

The Zacks Analyst Blog Highlights NVIDIA, Resmed, GE HealthCare and Medtronic

Zacks

2 months ago

The Zacks Analyst Blog Highlights NVIDIA, Resmed, GE HealthCare and Medtronic

NVIDIA's AI Speeds Up MedTech's Digital Boom: 3 Stocks in Focus

Zacks

2 months ago

NVIDIA's AI Speeds Up MedTech's Digital Boom: 3 Stocks in Focus

Zacks

2 months ago

RMD Stock Likely to Benefit From the New Brand Evolution Strategy

MT Newswires

2 months ago

Resmed Consolidating Brands, Product Lines Under Single Name

GlobeNewswire

2 months ago

Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution

Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)

StockStory

2 months ago

Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)

ResMed Among Top Stocks For Recent And Long-Term Profit Growth

Investor's Business Daily

2 months ago

ResMed Among Top Stocks For Recent And Long-Term Profit Growth

VEEV Stock Gains Following Latest Availability of HCP Access Data

Zacks

2 months ago

VEEV Stock Gains Following Latest Availability of HCP Access Data

Is it Worth Adding ResMed Stock to Your Portfolio Now?

Zacks

2 months ago

Is it Worth Adding ResMed Stock to Your Portfolio Now?

Zacks.com featured highlights include Taiwan, Tapestry, ABM Industries, Vertiv and ResMed

Zacks

2 months ago

Zacks.com featured highlights include Taiwan, Tapestry, ABM Industries, Vertiv and ResMed

5 Best Dividend Growth Stocks to Buy Amid Trade War Fears

Zacks

2 months ago

5 Best Dividend Growth Stocks to Buy Amid Trade War Fears

ResMed Stock Climbs 25.6% in a Year: What's Driving the Rally?

Zacks

2 months ago

ResMed Stock Climbs 25.6% in a Year: What's Driving the Rally?

MT Newswires

2 months ago

Stifel Adjusts Price Target on ResMed to $240 From $250, Maintains Hold Rating

Argus Research

2 months ago

RMD: Lowering target price to $243.00

VEEV Stock Falls Despite Latest Announcement to Enable AI Innovation

Zacks

2 months ago

VEEV Stock Falls Despite Latest Announcement to Enable AI Innovation

2 Reasons to Like RMD and 1 to Stay Skeptical

StockStory

2 months ago

2 Reasons to Like RMD and 1 to Stay Skeptical

Integra Q4 Earnings Beat Estimates, Revenues Rise Y/Y, Stock Up

Zacks

2 months ago

Integra Q4 Earnings Beat Estimates, Revenues Rise Y/Y, Stock Up

AMED Q4 Earnings and Revenues Miss, Margins Dip, Stock Rises

Zacks

2 months ago

AMED Q4 Earnings and Revenues Miss, Margins Dip, Stock Rises

TransMedics Stock Rises as Q4 Earnings & Revenues Beat Estimates

Zacks

3 months ago

TransMedics Stock Rises as Q4 Earnings & Revenues Beat Estimates

OPK Stock Gains Following Q4 Earnings Beat, Gross Margin Expands

Zacks

3 months ago

OPK Stock Gains Following Q4 Earnings Beat, Gross Margin Expands

Teleflex Stock Rises on Q4 Earnings Beat, Gross Margin Crashes

Zacks

3 months ago

Teleflex Stock Rises on Q4 Earnings Beat, Gross Margin Crashes

Chemed Q4 Earnings & Revenues Top, Stock Climbs, Margins Contract

Zacks

3 months ago

Chemed Q4 Earnings & Revenues Top, Stock Climbs, Margins Contract

ResMed (NYSE:RMD) shareholders have earned a 7.2% CAGR over the last five years

Simply Wall St.

3 months ago

ResMed (NYSE:RMD) shareholders have earned a 7.2% CAGR over the last five years

AVNS Stock Gains Post Q4 Earnings & Revenue Beat, Margins Contract

Zacks

3 months ago

AVNS Stock Gains Post Q4 Earnings & Revenue Beat, Margins Contract

TNDM Stock Falls in Aftermarket Following Q4 Earnings and Revenue Miss

Zacks

3 months ago

TNDM Stock Falls in Aftermarket Following Q4 Earnings and Revenue Miss

EYE Q4 Loss Narrower Than Expected, Margins Rise, Stock Surges

Zacks

3 months ago

EYE Q4 Loss Narrower Than Expected, Margins Rise, Stock Surges

MMSI Stock Gains in Pre-Market Post Q4 Earnings Beat, Margins Up

Zacks

3 months ago

MMSI Stock Gains in Pre-Market Post Q4 Earnings Beat, Margins Up

MASI Stock Gains Following Q4 Earnings Beat, Gross Margin Contracts

Zacks

3 months ago

MASI Stock Gains Following Q4 Earnings Beat, Gross Margin Contracts

Here's Why ResMed (RMD) is a Strong Growth Stock

Zacks

3 months ago

Here's Why ResMed (RMD) is a Strong Growth Stock

Alcon Q4 Earnings Beat, Margins Rise, Stock Remains Stable in Afterhours

Zacks

3 months ago

Alcon Q4 Earnings Beat, Margins Rise, Stock Remains Stable in Afterhours

ResMed’s Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor Sleep

GlobeNewswire

3 months ago

ResMed’s Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor Sleep

Argus Research

3 months ago

RMD: Raising target price to $248.00

HSIC Q4 Earnings Match Estimates, Margins Up, Stock Falls in Premarket

Zacks

3 months ago

HSIC Q4 Earnings Match Estimates, Margins Up, Stock Falls in Premarket

HIMS Stock Declines Following Q4 Earnings Miss, Gross Margin Contracts

Zacks

3 months ago

HIMS Stock Declines Following Q4 Earnings Miss, Gross Margin Contracts

MYGN Q4 Earnings Meet Estimates, Revenues Rise Y/Y, Stock Down

Zacks

3 months ago

MYGN Q4 Earnings Meet Estimates, Revenues Rise Y/Y, Stock Down

Veracyte Stock Falls Despite Q4 Earnings and Revenue Beat

Zacks

3 months ago

Veracyte Stock Falls Despite Q4 Earnings and Revenue Beat

ILMN Stock Might Rise From Collaboration With Broad Clinical Labs

Zacks

3 months ago

ILMN Stock Might Rise From Collaboration With Broad Clinical Labs

ResMed Inc. (NYSE:RMD) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Simply Wall St.

3 months ago

ResMed Inc. (NYSE:RMD) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

AMN Stock Gains Following Q4 Earnings & Revenues Beat, Margins Down

Zacks

3 months ago

AMN Stock Gains Following Q4 Earnings & Revenues Beat, Margins Down

Share on Social Networks: